glutathione monoethyl ester sigma reduced redox assays Research area Sigma-Aldrich Glutathione S-Transferase from equine
Description
doi: 10.1038/256463a0
Transgenic animal models to explore and modulate the blood brain and blood retinal barriers of the CNS
C.JamesB
AMPA receptor trafficking and synaptic plasticity
User experimentation suggests that longer initial treatment periods (6+ months continuous) support better benefit retention during subsequent breaks, complete discontinuation breaks of 1-2 months show acceptable benefit maintenance for most users, and very extended breaks (3-6+ months) increase risk of regression toward pre-treatment baseline particularly for short initial treatment courses
